Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-09-27
1997-10-21
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514285, 514287, 514291, 514293, 514300, 514301, 514302, 546 61, 546 65, 546 80, 546 83, 546 89, 546 98, 546123, 546156, 546158, A61K 3147, C07D21514
Patent
active
056796897
ABSTRACT:
Disclosed are new quinolone- and naphthyridonecarboxyclic acid derivatives of the formula: ##STR1## wherein T represents a radical of the formula: ##STR2## and the other radicals are as disclosed herein, for example, the compound 7-(3a-amino-1,2,3,7a-tetrahydro-isoindol-2-yl)-1-cyclopropyl-6-fluoro-1,4- dihydro-8-methoxy-4-oxo-3-quinolinecarboxyclic acid, their salts, antibacterial compositions containing them, processes for their preparation, and methods of using them to combat bacterial infections. Disclosed also are intermediates useful in said processes of preparation.
REFERENCES:
patent: 5508278 (1996-04-01), Jaetsch et al.
Derwent Abstract of JP 04-253923 (1990) Week 9243, pp. 9-10.
M. Sato et al, J. Med. Chem., vol. 35, pp. 4745-4750 (1992).
P. Newman, "Optical Resolution Procedures for Chemical Compounds", vol. 1, Optical Resolution Information Center, Manhattan College, Riverdale, N.Y. (1978).
G. Blaschke, Angew. Chem. Int. Ed. Eng., vol. 19, pp. 13-24 (1980).
Bremm Klaus-Dieter
Endermann Rainer
Petersen Uwe
Schenke Thomas
Bayer Aktiengesellschaft
Dahler Garth M.
Ivy C. Warren
LandOfFree
Quinolone- and naphthyridonecarboxylic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolone- and naphthyridonecarboxylic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolone- and naphthyridonecarboxylic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1007043